• Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Spain

  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Finland France Germany Greece Italy +3

  • Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Czechia Hungary Poland

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Greece

  • Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Ireland Italy Spain

  • Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +6

  • Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Denmark France Germany Greece Italy +4

  • Study on the Long-Term Safety of Sacituzumab Govitecan for Patients with Metastatic Solid Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Croatia Czechia Denmark Finland Germany +7

  • Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +10

powered by